NCT00293930CompletedPhase 3
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Astellas Pharma Inc32 sites in 2 countries645 target enrollmentStarted: February 20, 2006Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
- Astellas Pharma Inc
- Enrollment
- 645
- Locations
- 32
Study Overview
Brief Summary
A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 12 Years to — (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Clinical diagnosis of plaque psoriasis
Exclusion Criteria
- •Skin disorder other than plaque psoriasis in the areas to be treated.
- •Disease on only elbows, knees, and scalp
Investigators
Study Sites (32)
Loading locations...
Similar Trials
Completed
Phase 3
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of PsoriasisPsoriasisNCT00293891Astellas Pharma Inc658
Completed
Phase 3
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of PsoriasisPsoriasisNCT00293917Astellas Pharma Inc658
Completed
Phase 4
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic DermatitisDermatitis, AtopicNCT01828879Janssen-Cilag Ltd.,Thailand74
Completed
Phase 4
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic DermatitisDermatitis, AtopicNCT01782729Janssen-Cilag Ltd.,Thailand30
Completed
Phase 3
The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body PsoriasisPsoriasisNCT01139580Stiefel, a GSK Company363